TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Smerud Medical Research International AS
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
68,005
|
63,015
|
44,545 |
| Financial expenses |
927
|
1,396
|
2,004 |
| Earnings before taxes |
6,544
|
13,366
|
4,106 |
| Total assets |
29,984
|
26,631
|
33,533 |
| Current assets |
27,381
|
23,786
|
30,402 |
| Current liabilities |
13,326
|
14,790
|
24,478 |
| Equity capital |
16,657
|
11,842
|
9,055 |
| - share capital |
69
|
73
|
78 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
55.6%
|
44.5%
|
27.0% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
9.6%
|
21.2%
|
9.2% |
| Return on assets (ROA) |
24.9%
|
55.4%
|
18.2% |
| Current ratio |
205.5%
|
160.8%
|
124.2% |
| Return on equity (ROE) |
39.3%
|
112.9%
|
45.3% |
| Change turnover |
8,153
|
21,207
|
20,126 |
| Change turnover % |
14%
|
51%
|
82% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.